Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.560
-0.060 (-3.70%)
At close: Mar 18, 2026, 4:00 PM EDT
1.550
-0.010 (-0.62%)
After-hours: Mar 18, 2026, 7:51 PM EDT
Lexicon Pharmaceuticals Employees
Lexicon Pharmaceuticals had 81 employees as of December 31, 2025. The number of employees decreased by 22 or -21.36% compared to the previous year.
Employees
81
Change (1Y)
-22
Growth (1Y)
-21.36%
Revenue / Employee
$614,852
Profits / Employee
-$621,494
Market Cap
660.94M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 81 | -22 | -21.36% |
| Dec 31, 2024 | 103 | -182 | -63.86% |
| Dec 31, 2023 | 285 | 150 | 111.11% |
| Dec 31, 2022 | 135 | 48 | 55.17% |
| Dec 31, 2021 | 87 | 9 | 11.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Gyre Therapeutics | 579 |
| ProKidney | 204 |
| Prime Medicine | 146 |
| Annexon | 99 |
| Theravance Biopharma | 97 |
| AgomAb Therapeutics NV | 58 |
| Jade Biosciences | 55 |
LXRX News
- 7 days ago - Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies & Treatments for Diabetes - GlobeNewsWire
- 13 days ago - Lexicon Pharmaceuticals, Inc. (LXRX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Lexicon Pharmaceuticals Reports Fourth Quarter 2025 Financial Results and Provides Clinical Updates - GlobeNewsWire
- 15 days ago - Lexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences - GlobeNewsWire
- 20 days ago - Lexicon Pharmaceuticals to Report Fourth Quarter 2025 Financial Results on March 5, 2026 - GlobeNewsWire
- 5 weeks ago - Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement - GlobeNewsWire
- 6 weeks ago - Lexicon Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private Placement - GlobeNewsWire
- 6 weeks ago - Lexicon Announces Proposed Public Offering of Common Stock - GlobeNewsWire